Posos obtains CE class IIb marking providing a complete platform for Medical Software Publishers’ European expansion
Paris, January 9, 2024 - Posos, a medtech company specializing in AI-powered medical prescription assistance, announces that it has obtained CE class IIb marking for its medical devices. This certification, mandatory for any manufacturer wishing to market medical devices in Europe, enables Posos to offer medical software publishers a comprehensive solution to accelerate their European expansion: regulatory compliance, access to a multilingual medical database, state-of-the-art APIs and prescription security widgets. Posos thus offers a unique solution to deploy their solutions not only in France, with the offering being compatible with LAP and Digital Prescription criteria, but also in new European countries, while ensuring quality and safety in drug management for patients.
